Download as xls, pdf, or txt
Download as xls, pdf, or txt
You are on page 1of 34

Company Background

Company Name
Incorporation year
Industry group
Main product/service group
NSE symbol
First trading date on NSE
BSE group
First trading date on BSE

Sales Growth Over Last Ten Years


Ajanta Pharma Ltd.
1979
Drugs & pharmaceuticals
Drug formulations
AJANTPHARM
5-Jun-2000
B
5-Jun-2000

Year edning
March-03
March-04
March-05
March-06
March-07
March-08
March-09
March-10
March-11
March-12
March-13
March-14

(Rs. Million)
Sales
1024.4
1,206.5
1,788.0
2,123.7
2,471.7
2,916.9
3,224.3
3,850.0
4,624.1
6,123.7
8,452.4
11,099.2

Growth
17.8%
48.2%
18.8%
16.4%
18.0%
10.5%
19.4%
20.1%
32.4%
38.0%
31.3%

Firm A

FY
March-03
March-04
March-05
March-06
March-07
March-08
March-09
March-10
March-11
March-12
March-13
March-14

Sales
1024.4
1206.5
1788.0
2123.7
2471.7
2916.9
3224.3
3850.0
4624.1
6123.7
8452.4
11,099.2

Growth
17.8%
48.2%
18.8%
16.4%
18.0%
10.5%
19.4%
20.1%
32.4%
38.0%
31.3%

Borrowings
625.5
595.4
800.7
827.6
1084.9
1650.6
2402.2
2032.9
1582.9
1903.2
1234.6
566.1

Net Worth
1721.7
1725.3
1013.1
1096.5
1206.2
1342.0
1521.5
1759.1
2155.5
2718.4
3562.8
5363.2

PAT
42.6
3.6
74.4
103.5
137.1
177.9
213.8
285.4
464.5
664.9
1011.2
2208.6

Ret Profit
42.6
3.6
74.4
83.4
109.7
143.6
179.5
237.6
396.4
562.9
839.5
1797.0

(Rs. Million)
Total Assets
2504.6
2595.3
2043.5
2222.4
2721.8
3542.2
4582.9
4658.0
4808.6
6188.6
6760.5
8798.7

-30.1

3.6

90.7

205.3

-712.2

74.4

-551.8

26.9
257.3
565.7
751.6
-369.3
-450.0
320.3
-668.6
-668.5

83.4
109.7
135.8
179.5
237.6
396.4
562.9
844.4
1800.4

83.4
109.7
143.6
179.5
237.6
396.4
562.9
839.5
1797.0

178.9
499.4
820.4
1040.7
75.1
150.6
1380.0
571.9
2038.2

(Rs. Million)
Actual
Source
PUC
IGR
SGR
Sales Growth DER
Payout Ratio
118.0
0.36
0.0% Prowess
118.0
0.14%
0.21%
17.8%
0.35
0.0% Prowess
118.0
3.78%
7.93%
48.2%
0.79
0.0% Prowess
118.0
3.90%
8.23%
18.8%
0.75
19.4% Prowess
118.0
4.20%
10.00%
16.4%
0.90
20.0% Prowess
118.0
4.23%
11.98%
18.0%
1.23
19.3% Prowess
118.0
4.08%
13.38%
10.5%
1.58
16.0% Prowess
118.0
5.38%
15.62%
19.4%
1.16
16.7% Prowess
118.0
8.98%
22.53%
20.1%
0.73
14.7% Prowess
118.0
10.01%
26.11%
32.4%
0.70
15.3% Prowess
118.0
14.18%
30.83%
38.0%
0.35
17.0% Prowess
176.7
25.67%
50.39%
31.3%
0.11
18.6% Company AR
0.0 Div

411.6

171.7

PAT

2208.6

1011.2

1797.0

839.5

IGR = (PM * S * b) / (A PM * S * b)
SGR = b * ROE / (1 b * ROE)

b) / (A PM * S * b)

1 b * ROE)

3/31/2003
3/31/2004
3/31/2005
3/31/2006
3/31/2007
3/31/2008
3/31/2009
3/31/2010
3/31/2011
3/31/2012
3/31/2013
3/31/2014

Tot Capital Reserves an Def Tax Lai Current liab Borrowings Total assets
118
1603.7
39.6
117.8
625.5
2504.6
118
1607.3
68.1
206.5
595.4
2595.3
118
895.1
229.7
800.7
2043.5
118
978.5
298.3
827.6
2222.4
118
1088.2
430.7
1084.9
2721.8
118
1224
75.5
474.1
1650.6
3542.2
118
1403.5
131.2
528
2402.2
4582.9
118
1641.1
123.2
742.8
2032.9
4658
118
2037.5
188.6
881.6
1582.9
4808.6
118
2600.4
187.9
1379.1
1903.2
6188.6
118
3444.8
243.2
1719.9
1234.6
6760.5
176.7
5186.5
229.8
2639.6
566.1
8798.7

0
0
0
0
0
0
0
0
0
0
58.7

3.6
-712.2
83.4
109.7
135.8
179.5
237.6
396.4
562.9
844.4
1741.7

28.5
-68.1
0
0
75.5
55.7
-8
65.4
-0.7
55.3
-13.4

88.7
23.2
68.6
132.4
43.4
53.9
214.8
138.8
497.5
340.8
919.7

-30.1
205.3
26.9
257.3
565.7
751.6
-369.3
-450
320.3
-668.6
-668.5

Chng in Asset Source of Funding


90.7
90.7
-551.8
-551.8
178.9
178.9
499.4
499.4
820.4
820.4
1040.7
1040.7
75.1
75.1
150.6
150.6
1380
1380
571.9
571.9
2038.2
2038.2

DER
0.36
0.35
0.79
0.75
0.90
1.23
1.58
1.16
0.73
0.70
0.35
0.11

512.8
25
28.3

722
25
29.8

566.1

776.8

1714.4

1813

You might also like